glp-1 multiple sclerosis You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective Ozempic and Multiple Sclerosis: Insights

nausea, vomiting, diarrhoea, and constipation) are common [3, 5], serious adverse effects (e.g

A.: information is not available

Zepbound may offer greater weight loss benefits for some individuals, but both medications have similar side effects, such as nausea and gastrointestinal discomfort

And despite their popularity, many Americans face barriers to accessing these treatments due to high costs and limited insurance coverage

, Tran, M

The medication is FDA-approved for adults with obesity or those who are overweight with weight-related health conditions, making it an effective option for individuals struggling to lose weight through traditional methods alone